Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics
FE Skjeldestad, V Mehta, HL Sings… - Acta obstetricia et …, 2008 - Wiley Online Library
Background. Long‐term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.
FE Skjeldestad, V Mehta, HL Sings… - Acta Obstetricia et …, 2008 - europepmc.org
Background Long-term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics
FE Skjeldestad, V Mehta, HL Sings… - Acta obstetricia et …, 2008 - pubmed.ncbi.nlm.nih.gov
Background Long-term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics
FE Skjeldestad, V Mehta, HL Sings… - Acta Obstetricia et …, 2008 - Taylor & Francis
Background. Long-term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.
FE Skjeldestad, V Mehta, HL Sings, T Øvreness… - 2008 - cabidigitallibrary.org
Background. Long-term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
[引用][C] Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics
FE SKJELDESTAD, V MEHTA… - Acta obstetricia et …, 2008 - pascal-francis.inist.fr
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young
Norwegian women : study design and cohort characteristics CNRS Inist Pascal-Francis CNRS …
Norwegian women : study design and cohort characteristics CNRS Inist Pascal-Francis CNRS …
Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics.
FE Skjeldestad, V Mehta, HL Sings… - Acta Obstetricia et …, 2008 - search.ebscohost.com
Background. Long-term efficacy evaluations of a quadrivalent HPV type 6/11/16/18 vaccine
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …
are ongoing in the Nordic region. As there are limited epidemiological data on HPV infection …